Autolus Therapeutics plc Stock News

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) have been given an average rating of “Buy” by the six research firms that are covering the stock, Marketbeat reports. One research analyst has

Capital World Investors grew its holdings in shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 29.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange C

Alyeska Investment Group L.P. increased its position in Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 19.2% during the fourth quarter, according to the company in its most recent 13F filing with the S

Arix Bioscience (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-s

Fmr LLC decreased its position in shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 31.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi

Autolus Therapeutics (NASDAQ:AUTL) and Iovance Biotherapeutics (NASDAQ:IOVA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz

Shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) have been given an average rating of “Buy” by the six analysts that are currently covering the company, MarketBeat Ratings reports. One investm

Autolus Therapeutics (NASDAQ:AUTL) was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Tuesday, BidAskClub reports. Several oth

Autolus Therapeutics Ltd – (NASDAQ:AUTL) – Investment analysts at Jefferies Financial Group issued their Q1 2020 earnings per share estimates for Autolus Therapeutics in a research report issued o

Autolus Therapeutics Ltd – (NASDAQ:AUTL) – Equities research analysts at William Blair upped their Q1 2020 earnings per share (EPS) estimates for Autolus Therapeutics in a note issued to investors

Gilead Sciences (NASDAQ:GILD) and Autolus Therapeutics (NASDAQ:AUTL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analys